AURINIA PHARMACEUTICALS INC (AUPH)

CA05156V1022 - Common Stock

5.2  +0.11 (+2.16%)

After market: 5.25 +0.05 (+0.96%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
45.6M
-8.98%		134M
193.86%		175.513M
30.98%		228.73M
30.32%
EBITDA
YoY % growth
-177.94M
-72.87%		-108.79M
38.86%		-80.044M
26.42%		-2.754M
96.56%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-180.7M
-73.25%		-111.5M
38.30%		-91.691M
17.77%		-14.629M
84.05%
Operating Margin
-396.27%-83.21%-52.24%-6.40%
EPS
YoY % growth
-1.41
-90.54%		-0.76
46.10%		-0.54
28.95%		-0.06
89.61%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.14
22.55%
Revenue
Q2Q % growth		48.403M
40.67%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.699M
30.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.19
-5.56%		-0.17-0.02-14.05%
Q3 2023
Q2Q % growth		 -0.09
-50.00%		-0.170.0847.21%
Q2 2023
Q2Q % growth		 -0.08
68.00%		-0.190.1157.22%
Q1 2023
Q2Q % growth		 -0.18
33.33%		-0.230.0520.30%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 45.095M
58.56%		45.214M-119K-0.26%
Q3 2023
Q2Q % growth		 54.52M
-2.26%		39.275M15.245M38.82%
Q2 2023
Q2Q % growth		 41.49M
47.18%		38.91M2.58M6.63%
Q1 2023
Q2Q % growth		 34.41M
59.08%		28.432M5.978M21.03%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -1.24% 0% 84.13%
Revenue0% 9.97% 0% 4.44%